Research from the Buck Institute for Research on Aging reveals that the APOE4 variant, a significant genetic risk factor for Alzheimer’s disease, adversely affects bone quality in female mice. Despite normal imaging results, these mice exhibited marked deficits in bone strength, attributed to disruption of osteocytes, the cells responsible for maintaining bone microarchitecture. This study, published in Advanced Science, challenges the traditional view of Alzheimer’s as solely a brain disorder by demonstrating that the effects of APOE4 extend to skeletal health, indicating a systemic interplay between neurodegenerative and bone diseases.

The findings underscore a critical connection between osteocyte dysfunction and neurodegenerative risk, particularly in females, who are disproportionately affected by both Alzheimer’s and osteoporosis. The research highlights that while standard bone density scans can overlook subtle changes, mechanical testing revealed that bones from APOE4 carriers were significantly more fragile, with compromised material properties. This suggests that the deterioration in bone quality may serve as an early biological signal of cognitive decline, potentially allowing for earlier intervention in at-risk populations.

The implications for clinical practice are profound. Current diagnostic frameworks may fail to detect early signs of neurodegeneration as they primarily focus on structural changes rather than functional declines. This research advocates for a shift towards identifying new biomarkers that reflect osteocyte health and bone quality, which could lead to earlier detection and intervention strategies. Moreover, it opens avenues for therapies targeting bone remodeling pathways, emphasizing the need for a more integrated approach to aging research that considers the interconnectedness of various age-related conditions. By recognizing that signals of neurodegenerative risk may manifest in peripheral tissues, the study paves the way for a paradigm shift in how we understand and address aging and its associated diseases.

Source: longevity.technology